US Stock MarketDetailed Quotes
MDWD MediWound
- 16.350
- -1.130-6.46%
Close Aug 5 16:00 ET
- 17.530
- +1.180+7.22%
Post 17:49 ET
151.79MMarket Cap-12022P/E (TTM)
17.500High16.150Low150.03KVolume16.230Open17.480Pre Close2.49MTurnover2.92%Turnover RatioLossP/E (Static)9.28MShares24.00052wk High6.54P/B84.13MFloat Cap7.10052wk Low--Dividend TTM5.15MShs Float135.170Historical High--Div YieldTTM7.72%Amplitude7.100Historical Low16.628Avg Price1Lot Size
MediWound Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 30.67%4.96M | -29.48%18.69M | -54.05%5.34M | -17.70%4.78M | 2.25%4.77M | -13.80%3.8M | 11.50%26.5M | 111.74%11.62M | -8.93%5.8M | -22.93%4.67M |
| Operating revenue | 30.67%4.96M | -29.48%18.69M | -54.05%5.34M | -17.70%4.78M | 2.25%4.77M | -13.80%3.8M | 11.50%26.5M | 111.74%11.62M | -8.93%5.8M | -22.93%4.67M |
| Cost of revenue | 46.55%4.36M | 13.33%15.11M | 33.50%4.62M | 15.17%3.88M | 2.28%3.64M | 0.88%2.97M | -11.08%13.33M | -12.36%3.46M | -13.99%3.37M | -3.81%3.56M |
| Gross profit | -26.51%607K | -72.82%3.58M | -91.19%719K | -63.19%896K | 2.16%1.14M | -43.42%826K | 50.10%13.17M | 430.08%8.16M | -0.86%2.43M | -52.86%1.11M |
| Operating expense | -16.36%4.34M | -8.39%19.08M | -9.85%4.82M | -34.03%3.92M | 7.46%5.14M | 9.40%5.19M | 4.17%20.83M | 5.75%5.35M | 11.33%5.94M | -8.92%4.79M |
| Selling and administrative expenses | -7.03%2.87M | 9.70%11.38M | -4.84%2.56M | -14.67%2.61M | 36.42%3.12M | 32.19%3.09M | 9.71%10.37M | 16.02%2.69M | 25.35%3.06M | -12.04%2.29M |
| -Selling and marketing expense | 6.60%1.18M | 37.47%2.8M | ---- | ---- | ---- | --1.11M | 19.87%2.04M | ---- | ---- | ---- |
| -General and administrative expense | -14.63%1.69M | 2.90%8.57M | ---- | ---- | ---- | --1.98M | 7.48%8.33M | ---- | ---- | ---- |
| Research and development costs | -30.07%1.47M | -26.66%7.47M | -33.01%1.81M | -46.83%1.53M | -7.62%2.02M | -12.71%2.1M | -0.73%10.18M | 9.67%2.7M | -0.48%2.88M | -17.51%2.19M |
| Depreciation amortization depletion | ---- | -14.23%235K | ---- | ---- | ---- | ---- | -3.18%274K | ---- | ---- | ---- |
| -Depreciation and amortization | ---- | -14.23%235K | ---- | ---- | ---- | ---- | -3.18%274K | ---- | ---- | ---- |
| Other operating expenses | ---- | ---- | ---- | ---224K | ---- | ---- | ---- | ---- | ---- | --309K |
| Operating profit | 14.44%-3.73M | -102.34%-15.5M | -246.24%-4.11M | 13.82%-3.03M | -9.06%-4.01M | -32.89%-4.36M | 31.73%-7.66M | 179.72%2.81M | -21.71%-3.51M | -26.91%-3.67M |
| Net non-operating interest income expense | -983.28%-5.97M | 148.85%1.1M | -802.01%-5.39M | 228.22%877K | 830.03%4.94M | 324.58%676K | -26.00%-2.26M | -381.45%-597K | -49.67%-684K | -140.57%-676K |
| Non-operating interest income | ---- | 767.04%2.34M | ---- | ---- | ---- | ---- | 2,354.55%270K | ---- | ---- | ---- |
| Non-operating interest expense | ---- | --427K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Total other finance cost | 983.28%5.97M | -67.92%811K | 741.87%7.3M | -228.22%-877K | -830.03%-4.94M | ---676K | 180.89%2.53M | --867K | --684K | --676K |
| Other net income (expense) | 181.93%7.87M | -1,779.06%-9.6M | ||||||||
| Gain on sale of security | ---- | 185.85%7.66M | ---- | ---- | ---- | ---- | -1,645.21%-8.92M | ---- | ---- | ---- |
| Special income (charges) | ---- | --211K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Less:Other special charges | ---- | ---211K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non- operating income (expenses) | ---- | ---- | ---- | ---- | ---- | ---- | ---684K | ---- | ---- | ---- |
| Income before tax | -163.15%-9.71M | 66.54%-6.53M | 78.04%-1.62M | 48.78%-2.15M | 121.33%928K | -2.87%-3.69M | -44.34%-19.52M | -77.86%-7.39M | -25.53%-4.19M | -36.96%-4.35M |
| Income tax | 380.00%24K | 137.18%185K | 84.62%120K | 860.00%48K | 200.00%12K | 25.00%5K | 188.89%78K | 1,525.00%65K | 25.00%5K | -78.95%4K |
| Net income | -163.44%-9.73M | 65.73%-6.72M | 76.63%-1.74M | 47.70%-2.2M | 121.04%916K | -2.90%-3.69M | -44.63%-19.6M | -79.25%-7.46M | -25.53%-4.2M | -36.28%-4.35M |
| Net income continuous Operations | -163.44%-9.73M | 65.73%-6.72M | 76.63%-1.74M | 47.70%-2.2M | 121.04%916K | -2.90%-3.69M | -44.63%-19.6M | -79.25%-7.46M | -25.53%-4.2M | -36.28%-4.35M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -163.44%-9.73M | 65.73%-6.72M | 76.63%-1.74M | 47.70%-2.2M | 121.04%916K | -2.90%-3.69M | -44.63%-19.6M | -79.25%-7.46M | -25.53%-4.2M | -36.28%-4.35M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -163.44%-9.73M | 65.73%-6.72M | 76.63%-1.74M | 47.70%-2.2M | 121.04%916K | -2.90%-3.69M | -44.63%-19.6M | -79.25%-7.46M | -25.53%-4.2M | -36.28%-4.35M |
| Basic earnings per share | -138.64%-1.05 | 80.92%-0.75 | 83.90%-0.19 | 72.73%-0.24 | 110.87%0.1 | 49.43%-0.44 | -12.93%-3.93 | -12.38%-1.18 | -4.76%-0.88 | -9.52%-0.92 |
| Diluted earnings per share | -138.64%-1.05 | 80.92%-0.75 | 83.90%-0.19 | 72.73%-0.24 | 110.87%0.1 | 49.43%-0.44 | -12.93%-3.93 | -10.41%-1.18 | -4.76%-0.88 | -9.52%-0.92 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg